0000899243-18-007927.txt : 20180319 0000899243-18-007927.hdr.sgml : 20180319 20180319160603 ACCESSION NUMBER: 0000899243-18-007927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sprague John M CENTRAL INDEX KEY: 0001730056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 18698777 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-15 0 0001492674 T2 Biosystems, Inc. TTOO 0001730056 Sprague John M 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 CFO Performance Restricted Stock Units 2018-03-15 4 A 0 69170 0.00 A 2021-03-15 Common Stock 69170 69170 D Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three-year performance period /s/ Michael Gibbs, Attorney-in-Fact 2018-03-19